GLOBAL POINT OF CARE

ID NOW™: When time matters

The ID NOW™ molecular respiratory testing platform delivers fast, reliable results, enabling you to expand your lab’s impact, reach, and efficiency while maintaining control of critical diagnostics

Learn More Here
For In Vitro Diagnostic Use Only
For In Vitro Diagnostic Use Only

ID NOW™: When time matters

The ID NOW™ molecular respiratory testing platform delivers fast, reliable results, enabling you to expand your lab’s impact, reach, and efficiency while maintaining control of critical diagnostics

Learn More Here
When time matters - ID Now When time matters - ID Now When time matters - ID Now
When time matters - ID Now

The ID Now Difference

Accurate, actionable results during the first patient encounter*

ID NOW™ is the only POC molecular testing platform to provide results in 13 minutes or less for SARS-CoV-2, Influenza A & B, RSV, and Strep A. With accuracy equivalent to RT-PCR and superior to rapid antigen-based tests, ID NOW™ extends your diagnostic resources beyond the central lab to the actual sites of patient care, so clinicians can start the right treatment sooner.

Clinical Performance Infographic Clinical Performance Infographic Clinical Performance Infographic

The point-of-care platform that improves your processes

ID NOW™ integrates seamlessly into acute care settings. By reducing delays, shortening turnaround times, and freeing up personnel and resources for other essential diagnostics, ID NOW™ can enhance your lab’s testing capacity and help reduce strain on hospital utilities and resources.

Watch the video to explore how id now™ can optimise your respiratory testing pathway at the point of care.

watch now

Watch Dr. Yusuf Gray, Advanced Biomedical Scientist, discuss his experience with ID NOW™ in the ED.

watch now

ID NOW™ offers greater sensitivity than POC LFA or FIA

The ID NOW™ platform’s isothermal NEAR technology utilizes proprietary enzymes and constant temperatures to provide rapid results with superior sensitivity. ID NOW™ detects more true positives for SARS-CoV-2, Influenza A & B, and RSV than rapid antigen tests,1-3,6,7 and eliminates the need for additional culture confirmation of Strep A,5 further reducing the burden on your lab.

Clinical Performance Infographic Clinical Performance Infographic

*76% of emergency ED clinicians spend less than 16 minutes with a patient.8

† Within 7 days of symptom onset.

‡ Results are specific to direct swab.

ED: emergency department; pED: pediatric emergency department; EMR: electronic medical record; FIA: fluorescence immunoassay; LFA: lateral flow assay; POC: point of care; PPV: positive predictive value; RT-PCR: reverse transcription polymerase chain reaction; UTM: universal transport medium; VTM: viral transport medium.

  1. ID NOW™ COVID-19 2.0 Product Insert.
  2. ID NOW™ Influenza A & B 2 Product Insert.
  3. ID NOW™ RSV Package Insert. Abbott Diagnostics Scarborough, Inc.; 2020. https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/ID_Now_RSV_Package_Insert.pdf.
  4. ID NOW™ Strep A 2 Product Insert.
  5. Abbott. Data on File. ID NOW™ TM Strep A 2 clinical assertion data.
  6. Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chainreaction: A systematic review and meta-analysis. Ann Intern Med. 2017;167(6):394-409.
  7. Chartrand, C. et al. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: Systematic review and meta-analysis. J Clin Microbiol.2015;53(12):3738-3749.
  8. Grisham S. Medscape Emergency Medicine Physician—Physician Compensation Report 2017. Accessed December 18, 2024.https://www.medscape.com/slideshow/compensation-2017-emergency-medicine-6008568.

©2025 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.